Risk of cancer from azathioprine therapy in multiple sclerosis: A case-control study
β Scribed by Confavreux, C.; Saddier, P.; Grimaud, J.; Moreau, Th.; Adeleine, P.; Aimard, G.
- Book ID
- 115442531
- Publisher
- Lippincott Williams and Wilkins
- Year
- 1996
- Tongue
- English
- Weight
- 797 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0028-3878
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The results of a prospective, long-term controlled study on the treatment of multiple sclerosis with azathioprine are reported. The effect of a daily 2 mg/kg body weight dosage on 56 randomly chosen patients with multiple sclerosis is compared with a non-treated control group of 51 randomly selected
## Abstract The aim of our study was to explore restless legs syndrome (RLS) frequency in multiple sclerosis (MS)βpatients and establish whether RLS could be a symptom of MS. Over a period of 1 year, we consecutively enrolled 202 MSβpatients and 212 healthy controls, matched for sex and age, in a c